Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.6225
+0.0803 (14.81%)
Aug 15, 2025, 3:42 PM - Market open
Plus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 2.23 | 0.08 | 8.55 | 18.12 | 18.4 | 8.35 | Upgrade |
Short-Term Investments | 4.65 | 3.53 | - | - | - | - | Upgrade |
Cash & Short-Term Investments | 6.88 | 3.61 | 8.55 | 18.12 | 18.4 | 8.35 | Upgrade |
Cash Growth | -18.45% | -57.84% | -52.79% | -1.52% | 120.47% | -52.45% | Upgrade |
Accounts Receivable | 1.02 | 0.57 | - | - | - | - | Upgrade |
Receivables | 1.02 | 0.57 | - | - | - | - | Upgrade |
Prepaid Expenses | - | 0.65 | 1.05 | 3.7 | 1.32 | 0.77 | Upgrade |
Other Current Assets | 1.31 | 0.44 | 0.23 | - | 0.01 | 0.06 | Upgrade |
Total Current Assets | 9.21 | 5.26 | 9.83 | 21.82 | 19.72 | 9.18 | Upgrade |
Property, Plant & Equipment | 0.32 | 0.52 | 1.11 | 1.57 | 1.82 | 2.46 | Upgrade |
Goodwill | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | Upgrade |
Other Intangible Assets | 0.4 | 0.47 | 0.04 | 0.09 | 0.05 | 0.09 | Upgrade |
Other Long-Term Assets | 0.05 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | Upgrade |
Total Assets | 10.35 | 6.63 | 11.39 | 23.87 | 21.98 | 12.11 | Upgrade |
Accounts Payable | 6.36 | 9.47 | 4.76 | 8.36 | 2.61 | 0.79 | Upgrade |
Accrued Expenses | - | 1.81 | 1.87 | 1.77 | 1.42 | 1.26 | Upgrade |
Short-Term Debt | - | 3.29 | - | - | - | - | Upgrade |
Current Portion of Long-Term Debt | - | - | 3.98 | 1.61 | 1.61 | 6.34 | Upgrade |
Current Portion of Leases | 0.03 | 0.04 | 0.12 | 0.11 | 0.11 | 0.13 | Upgrade |
Current Unearned Revenue | 0.93 | 0.93 | - | - | - | - | Upgrade |
Other Current Liabilities | - | - | - | - | 0.12 | 0.02 | Upgrade |
Total Current Liabilities | 7.32 | 15.55 | 10.73 | 11.85 | 5.87 | 8.54 | Upgrade |
Long-Term Debt | - | - | - | 3.79 | 5.01 | - | Upgrade |
Long-Term Leases | - | 0.03 | 0.09 | 0.14 | 0.27 | 0.53 | Upgrade |
Long-Term Unearned Revenue | - | - | 1.92 | 1.64 | - | - | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 0 | 0.01 | Upgrade |
Total Liabilities | 7.32 | 15.58 | 12.74 | 17.42 | 11.15 | 9.07 | Upgrade |
Common Stock | 0.09 | 0.01 | 0.01 | 0 | 0.02 | 0.01 | Upgrade |
Additional Paid-In Capital | 509.17 | 485.02 | 479.27 | 473.63 | 457.73 | 436.54 | Upgrade |
Retained Earnings | -505.73 | -493.48 | -480.5 | -467.19 | -446.91 | -433.51 | Upgrade |
Treasury Stock | -0.5 | -0.5 | -0.13 | - | - | - | Upgrade |
Shareholders' Equity | 3.03 | -8.95 | -1.35 | 6.45 | 10.84 | 3.03 | Upgrade |
Total Liabilities & Equity | 10.35 | 6.63 | 11.39 | 23.87 | 21.98 | 12.11 | Upgrade |
Total Debt | 0.03 | 3.37 | 4.18 | 5.65 | 6.99 | 7 | Upgrade |
Net Cash (Debt) | 6.85 | 0.24 | 4.37 | 12.48 | 11.41 | 1.35 | Upgrade |
Net Cash Growth | 36.95% | -94.53% | -64.95% | 9.36% | 744.96% | -75.77% | Upgrade |
Net Cash Per Share | 0.42 | 0.03 | 1.39 | 7.13 | 14.15 | 4.57 | Upgrade |
Filing Date Shares Outstanding | 99.26 | 17 | 4.28 | 2.34 | 1.48 | 0.45 | Upgrade |
Total Common Shares Outstanding | 92.18 | 5.9 | 4.44 | 2.24 | 1.03 | 0.45 | Upgrade |
Working Capital | 1.9 | -10.29 | -0.89 | 9.97 | 13.85 | 0.64 | Upgrade |
Book Value Per Share | 0.03 | -1.52 | -0.30 | 2.88 | 10.48 | 6.74 | Upgrade |
Tangible Book Value | 2.26 | -9.79 | -1.76 | 5.98 | 10.41 | 2.57 | Upgrade |
Tangible Book Value Per Share | 0.02 | -1.66 | -0.40 | 2.67 | 10.07 | 5.72 | Upgrade |
Machinery | - | 1.78 | 1.63 | 1.47 | 1.23 | 1.53 | Upgrade |
Leasehold Improvements | - | 1.81 | 1.81 | 1.81 | 1.66 | 1.68 | Upgrade |
Updated May 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.